Skip to main content

and
  1. Article

    Open Access

    Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation

    This study aimed to identify the benefits of autologous-stem cell transplantation (auto-SCT) and allogeneic-SCT (allo-SCT) in patients with aggressive T-cell lymphomas to aid in the selection of transplantatio...

    Dong Won Baek, Joon Ho Moon, Jae Hoon Lee, Ka-Won Kang, Ho Sup Lee in Blood Cancer Journal (2023)

  2. Article

    Open Access

    Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

    The development of new treatment agents in recent decades has significantly improved the survival of patients with multiple myeloma (MM). Nonetheless, MM remains an incurable disease; therefore, novel combinat...

    Jaya Lakshmi Thangaraj, Sung-Hoon Jung, Manh-Cuong Vo in Cancer Immunology, Immunotherapy (2023)

  3. No Access

    Article

    Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21

    Natural killer (NK) cell-based immunotherapy is a promising treatment approach for multiple myeloma (MM), but obtaining a sufficient number of activated NK cells remains challenging. Here, we report an improve...

    Jaya Lakshmi Thangaraj, Minh-Trang Thi Phan in Cancer Immunology, Immunotherapy (2022)

  4. Article

    Open Access

    Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma

    Recently, the endothelial Activation and Stress Index (EASIX) score has been reported to predict overall survival (OS) after allogeneic stem cell transplantation. This study evaluated the prognostic role of EA...

    Ga-Young Song, Sung-Hoon Jung, Kihyun Kim, Seok ** Kim, Sang Eun Yoon in BMC Cancer (2020)

  5. Article

    Open Access

    Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma

    For successful autologous stem cell transplantation, the collection of a sufficient number of hematopoietic stem cells after induction therapy is essential for transplant candidates with multiple myeloma (MM).

    Ga-Young Song, Sung-Hoon Jung, Seo-Yeon Ahn, Seung-Yeon Jung, Deok-Hwan Yang in BMC Cancer (2019)